This article describes the extreme right in the Czech Republic, where, in contrast to several other countries of Central and Eastern Europe, this part of the political spectrum has been unsuccessful for the past ten years. The aim of this article is to analyse the position of the extreme right in the Czech party system and the internal ideological and strategic cleavages within the extreme right. The conclusion of this article is that organized party-political extremism is after two decades of modern political development only a marginal part of the Czech political spectrum, with many internal problems and without real chances of significant success in the near future.
The success of Jobbik, an extreme-right party in Hungary, is unique in its success compared with other extreme right parties in the Visegrad 4 countries of Central Europe. In contrast to parties in the Czech Republic, Slovakia, and Poland, Jobbik has managed to make substantial electoral gains and is a major player in the National Assembly in Hungary. This paper discusses five factors that show how the rise of Jobbik was possible. They are: a tradition of extreme right political movements, a party cleavage structure shaped by morals rather than socioeconomics, a specific national electoral geography, the negotiation style of the party and finally its reaction on the crisis of traditional democratic parties. In contrast to the other V4 nations, only Hungary has these elements present. This text explores each of these factors in a comparative context to demonstrate how Jobbik was able to take advantage of Hungarian political conditions in a way that extreme right parties in other Central European nations cannot.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.